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Abstract
It is well established that regular physical activity reduces cardiovascular disease risk;
however, numerous studies have demonstrated postexercise elevations in cardiac
troponin (cTn), indicative of cardiac injury in apparently healthy individuals. The prev-
alence of these findings in different exercise settings and population groups, as well
as potential underlying mechanisms and clinical significance of exercise-induced cTn
release are not yet quite determined. The present review will discuss the cTn
response to exercise in light of developing cTn assays and the correlation between
postexercise cTn release and cardiac function. Additionally, recent data regarding the
potential link between strenuous endurance exercise and its relationship with unfa-
vorable cardiac effects in athletes, as well as the management of patients presenting
at emergency care after sport events will be briefly reviewed.
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1 | INTRODUCTION
Studies carried out since 1987 using early experimental troponin
(Tn) assays have shown that prolonged exercise may induce detectable
increase in circulating troponins.1 Driven by the development of more
sensitive and specific assays, cardiac Tn (cTn) have progressively formed
the cornerstone for the diagnosis of acute myocardial infarction (MI),
beginning from the first definition2 in 2000, until the recently published
Fourth universal definition of MI3 in 2018. It is recognized that many
nonacute coronary syndrome (ACS) diagnoses and other conditions may
also promote cTn elevation, including prolonged exercise.4
The introduction of the high-sensitivity troponin assays,
unsurpassed in sensitivity to detect low levels of myocardial damage
(possibly at the expense of decreased specificity)5 has allowed better
characterization of exercise-induced cTn elevation. This has led to the
observation that measurable changes in cTn are common, not only
with extreme levels of exercise, such as marathon,6 but even following
normal physical activity,7 or a treadmill test.8 The origin of this bio-
marker release and whether it reflects a physiological or pathological
process, remains a contentious issue.9 The clinical implications are
worthy of study for a number of reasons. First, this issue may be of
relevance to the controversy surrounding the long-term prognosis of
athletes presenting with postexercise cTn elevations and the possible
role of high level exercise as a cause of cardiac disease in some indi-
viduals.10 Although the beneficial effect of moderate duration exer-
cise on cardiovascular health in the general population is well
recognized,11 it has been postulated that participation in multiple
extreme endurance events may lead to right ventricular
(RV) dysfunction,12 accelerate coronary atherosclerosis,13 or even
promote cardiac fibrosis.14 Second, exercise-induced cTn elevation is
important to understand in the management of athletes presenting
with chest pain at emergency care after sport events, since in many
relevant studies cTn levels exceeded the 99 percentile of the method
formally fulfilling the criteria for acute MI.15
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creatine kinase-myocardial band; cMRI, cardiovascular magnetic resonance; CTCA, computed
tomography coronary angiography; cTn, cardiac troponin; cTnI, cardiac troponin I; cTnT,
cardiac troponin T; LV, left ventricular; MI, myocardial infarction; RV, right ventricular; Tn,
troponin.
Received: 20 July 2019 Revised: 7 January 2020 Accepted: 9 January 2020
DOI: 10.1002/clc.23337
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.
Clinical Cardiology. 2020;1–10. wileyonlinelibrary.com/journal/clc 1
Previous reports have repeatedly confirmed that cTnT levels at
rest can be predictive of future cardiovascular events, not only in the
context of CAD or other diseases,16,17 but even in apparently healthy
individuals.18 In contrast, cTn elevation postexercise has been com-
monly considered a physiological response and a benign, physiological
phenomenon in terms of prognosis19,20; nevertheless, this theory has
been challenged by recent studies suggesting that exercise-induced
cTn release may be related to an increased incidence of adverse car-
diovascular events,21 or occult obstructive CAD.22
This review will summarize available data with regards to the cTn
response to exercise and will evaluate this data with reflection on
research design, exercise stimulus, participant selection as well as
assay development and cTn biochemistry. Potential mechanism, clini-
cal significance, and the management of patients with cTn elevation
after exercise will be briefly discussed.
2 | METHODS
We performed a review of studies related to the cTn response to
exercise. A review of research published in English until September
2019 was performed, by conducting systematic searches of PubMed,
Scopus and the Cochrane Library, using the Key words “Exercise-
induced troponin,” “Troponin release,” “Troponin physiology,” “Cardiac
biomarkers and exercise,” and “Exercise-induced cardiac damage,”
“Exercise-induced cardiac injury.” Studies that were repetitions were
removed. Additional studies were excluded by reading the headlines
or abstracts, if they did not concern exercise-induced elevation of tro-
ponin in healthy subjects, or if there were not available in English. The
reference lists of the retrieved articles and the review articles publi-
shed on the subject were also screened for eligible manuscripts. All
studies were published between 1987 and 2019.
3 | RESULTS AND DISCUSSION
3.1 | Exercise factors
Early reports of exercise-induced elevations in serum biomarkers,
mainly myocardial band isoform of creatine kinase (CK-MB), led to the
concern that high intensity physical activity may result in cardiac
injury, which was mitigated by the discovery that CK-MB lacks speci-
ficity regarding cardiac or skeletal muscle origin.23 The development
of Tn assays has expanded the ability to explore exercise-induced car-
diac injury. Fortescue et al,6 in one of the largest relevant reports,
studied 482 Boston marathon finishers and found that 68% had some
degree of postrace cTn elevation, while 11% of those had increases
diagnostic for MI. Interestingly, this increase was found to be more
pronounced in less trained athletes, which was confirmed by other
reports,24 while several others found no association between training
status and biomarker release.25 Multiple other studies have reported
cTn elevations after marathons,26 ultradistance races,27 triathlon
events,28 cycling,29 and various other forms of physical activity.
Exercise intensity and duration cannot reliably predict the magnitude
of cTn release.30-32 Furthermore, aside from extreme sports, detect-
able biomarker alterations have been described following stress
tests,33 table tennis games,34 or prolonged walking.35 It should also be
noted that numerous studies found no significant release of cTn, even
after high-intensity exercise.36 The discrepancy in reports investigat-
ing prevalence and factors affecting the release of cTn directly chal-
lenges clinical relevance and supports the hypothesis that it may not
actually reflect cardiac injury.
In order to explore a potential association between cTn release
and cardiac function, numerous studies have coupled cTn with imag-
ing modalities (echocardiography, cMRI) and biochemical markers
(mainly N-terminal pro-B-type natriuretic peptide) after endurance
events; nevertheless, results from such efforts have also been incon-
sistent. (Table 1).
La Gerche et al12 studied 40 athletes following an ultra-
endurance race event and showed that cTnI and B-type natriuretic
peptide were increased postrace and correlated with decrements in
RV, but not LV function, as estimated by echo and cMRI, yet, these
effects were reversible after a week. In contrast, Wilson et al37 found
no association between post-marathon cTnI release and echo/cMRI
cardiac function indices. The term “cardiac fatigue” has been used to
describe the postexercise decline in systolic and diastolic LV and RV
function,38 that in most studies do not seem to correlate with cTn ele-
vation. In general, most of the reports incorporating imaging and addi-
tional biochemical markers suggest that, even if there is evidence for
transient LV or RV dysfunction, there is no solid data suggesting that
this is translated to permanent damage.12,35,39-41 This is in line with
good prognosis and longevity of athletes,42 even when volume of
exercise exceeds significantly the officially recommended
150 minutes per week of moderate intensity or 75 minutes per week
of vigorous-intensity aerobic exercise per week.43
3.2 | STUDY DESIGN FACTORS
The marked heterogeneity in studies regarding postexercise cTn
release has been attributed to various factors, including small sample
sizes, differences in fitness of participants, varying types and intensity
of exercise, different cTn assays, as well as different detection limits
used to define a “positive” cTn.44 Timing of blood sampling may be a
major determinant of this variability,26 considering, not only the diver-
sity in cTn elevation kinetics pattern between the well-studied CAD
syndromes vs exercise, but also the uncertainty regarding the actual
peak value of cTn. Especially in the context of long duration sport
events, multiple or even delayed (24 hours postexercise) sampling
may be required in order to disclose a comprehensive trend of cTn.45
Furthermore, Kleiven et al,22 in a study performed in 120 middle aged
predominately male cyclists, showed that cTn elevation 24 hours
poststrenuous exercise was more pronounced in subjects with occult
obstructive CAD compared to those without significant stenosis,
while no difference was observed prior to or 3 hours after the race.
Thus, if confirmed by other studies, this indicates that delayed
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sampling may entail clinical relevance, potentially contributing in the
identification of high-risk individuals.
Meta-analyses and systematic reviews, that would hopefully
yield the adequate overall sample size necessary to provide greater
statistical reliability and insights to mechanisms and sources of dis-
crepancy have also been conducted (Table 2). Shave et al,46 retriev-
ing data from studies up until 2006, showed that 47% of endurance
athletes experienced a significant exercise-induced rise in cTnT and
that 36% of London marathon finishers demonstrated cTnT eleva-
tions fulfilling criteria for MI. These results are similar to those
reported by others,47,48 while the increased prevalence reported in
the study be Vilela et al49 (70% out of 424 participants retrieved
from eight studies showed post-running cTn values higher than the
99th URL) probably reflects the currently broader utilization of
high-sensitivity assays. Gresslien et al50 provide a detailed selection
of the more recent relevant studies, but no conclusive data are
reported.
4 | POTENTIAL MECHANISMS OF
EXERCISE-INDUCED CTN RELEASE
4.1 | Troponin physiology
The cTn complex, consisting of three proteins known as cTnC, cTnI,
and cTnT, forms the skeleton of the striated muscle and regulates
actin and myosin cross-bridge cycling. cTn is bound to tropomyosin
on the thin filament of the myofibril, while an undefined proportion
remains unbound in cytosolic pool, possibly serving as a reservoir for
repair/regeneration of tropomyosin-bound cTn.51 Although skeletal
TABLE 1 Studies investigating correlations between cTn elevation and cardiovascular effects
Author
Publication
year Type of exercise Functional indices cTn NT-proBNP
Correlations
between cTn
and functional
indices
Weippertet al78 2016 60 min moderate intensity
CT vs sprints with set RPs
in-between
TTE: - " in RP −
O'Hanlon et al84 2010 Marathon CMR: - "cTnI −
Neilan et al39 2006 Marathon TTE: diastolic-RV
dysfunction
"cTnT " +
Mousavi et al40 2009 Marathon TTE, CMR: RV dysfunction "cTnT +
Shave et al85 2002 Mountain marathon TTE: LV dysfunction "cTnT −
George et al86 2009 Ultra marathon, 89 km TTE: # EF,
#peak strain-peak systolic,
diastolic strain rates
"cTnT −
Tulloh et al87 2006 Ironman Triathlon TTE: transient
# EF
"cTnT +
Rifai et al88 1999 Ironman Triathlon TTE: transient #EF "cTnT, ±"cTnI + (significant in
those with
both "cTnT
and "cTnI)
Wilson et al37 2011 Marathon TTE: transient LV # diastolic
function
CMR: -
"cTnI " −
Whyte et al89 2005 Marathon TTE: LV # diastolic function "cTnT −
George et al41 2004 Marathon TTE: LV # diastolic function "cTnT −
Shave et al90 2004 Two 50 mile cycle trials TTE: - − −
Scharhag et al91 2006 1-h and a 3-h exercise study TTE: -
CMR: -
"cTnI " −
La Gerche et al12 2012 Endurance race (3-11 h
duration)
TTE: RV dysfunction
CMR: RV dysfunction
"cTnI " Correlations of
biomarkers
with RVEF
but not LVEF
Bohm et al92 2016 Cardiopulmonary exercise
testing
TTE: -
CMR: -
"cTnT −
Note: " means elevation, − means no significant effect, and + means positive correlation.
Abbreviations: cMRI, cardiovascular magnetic resonance; CT, continuous training; EF, ejection fraction; LV, left ventricular; NT-proBNP, N-terminal pro-B-
type natriuretic peptide; RV, right ventricular; TTE, transthoracic echocardiogram.
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and cTn proteins demonstrate a significant degree of amino acid
sequence homology, more than 100 differences exist and they are
encoded by separate genes.52 Important biological and analytical dif-
ferences also exist between cTnT and cTnI. During fetal development,
cTnT exists in both cardiac and skeletal muscles, but disappears gradu-
ally from adult skeletal muscle, yet, it may be reexpressed in case of
skeletal muscle injury.52,53 TnI has also been previously reported to
possess skeletal expression; however, relevant data are scarce.54
Consistent with both cytosolic and structural distribution of cTn,
the appearance in blood following injury, exhibits a biphasic release pat-
tern.55 The kinetics of postexercise Tn release, with an early peak and
quick normalization, is quite different from the elevation pattern
observed in ACSs,56 or even ablation,57 indicating that exercise-induced
cTn elevation may arise from the cytosol and not from the thin fila-
ments in the contractile apparatus58-60(Figure 1).
Another issue to be considered when interpreting cTn levels, is
that the antibodies comprising Tn immunoassays may be susceptible
to cross reactions induced by immunologic factors or heterophilic
antibodies, creating a source of false positive results. Such reactions
have been described in relation to the presence of rheumatoid
factor,61 or diseases like myasthenia.62 Various hypotheses have been
proposed for the pathophysiologic mechanisms underlying cTn eleva-
tion post exercise, including increased membrane permeability, normal
turnover of myocardial cells, cTn degradation products cellular release,
TABLE 2 Systematic reviews—meta-analyses investigating exercise-induced cTn release
Author
Publication
year
Number of
studies
Patients
included
CTnT (% of subjects
with elevation) Remarks
Shave et al46 2007 26 1120 47 Postexercise cTnT after cycling approximately half that of
running events (27% vs 52%)
Postexercise cTnT not affected by age
Sedaghat-Hamedani
et al47
2015 33 1045 51 Average cTnI elevation 40 ng/L c from baseline, no %
reported due to significant heterogeneity between studies
Regwan et al48 2010 16 939 51 Marathon participants
cTn elevation not associated with age and gender, but with
publication date and assay sensitivity
cTnI less commonly elevated vs cTnT
Vilela et al49 2014 10 424 69.8
Gresslien et al50 2016 145 0%-100% Extremely thorough citation of studies, but no cumulative data
provided
F IGURE 1 This shows the
schematics of the troponin
release after myocardial infarction
(MI) vs endurance exercises.
Prolonged exercise can increase
cardiomyocyte membrane
permeability and secretion of
cytoplasmic-free cardiac troponin.
On the contrary, troponin
elevation in MI is due to
cardiomyocyte necrosis and
release of myofilament-bound
troponin60
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membranous blebs, myocyte apoptosis/necrosis resulting in genuine
cardiac injury, skeletal muscle origin of cTn. The exact etiology
remains still speculative due to limited empirical data,63,64 but the
most common theories are briefly discussed below.
4.2 | Increased membrane permeability
Starnberg et al58 performed in vitro studies from human cardiac tissue
and found that transient cytosolic leakage of cytosolic cTn might be
facilitated by increases in myocardial sarcolemmal permeability, possi-
bly propagated, among others, by free radical mediated injury.64 Free
radical generation can be induced by mechanical stress on the
cardiomyocytes, increased body temperature, or prolonged acidosis.65
Whenever the capacity of the lymphatics to remove macromolecules
is exceeded, cTn becomes detectable in the peripheral circulation.
This passive diffusion of cTn from the intracellular to extracellular
compartment, which has also been described in skeletal muscle
exposed to exercise,66 is compatible with the release kinetics of cTn
observed in this setting; nevertheless, no specialized biological pro-
cess (eg, exocytosis) has been experimentally proved to serve this
scope.67
4.3 | Cardiac injury
Myocardial injury, differentiated by MI and irreversible damage, may
be acute, as evidenced by a newly detected dynamic rising and/or fall-
ing pattern of cTn, or chronic, in the case of persistently elevated cTn
levels.3 Exercise provoked mechanical stimuli might induce transient
disruptions of the myocardial plasma membrane, termed “cell
wounds,” also stimulated by integrins.68 This process does not result
in frank myocardial injury or cell necrosis, because cardiac regenera-
tive capacity (1% per year in adults over 25 year, 0.3% at the age of
75) would not be sufficient to maintain contractile capacity and com-
pensate the amount of cumulative injury indicated by cTn values
observed in repeated sport events.69 However, multiple bouts of
mechanical stress forces may elicit stretching of the myocytes, stimu-
lated also by inflammatory pathways, as evidenced by interleukin and
neutrophil count increase in response to exercise.70 These repeated
episodes with cTn elevation, followed by immediate restoration of
normality may represent a physiological repairing, or remodeling pro-
cess. In this context, the fibrotic lesions14 and calcified, yet stable,
atheromatic plaques13,71 observed to a greater extent in lifelong
endurance athletes, may be the expression of these pathways in the
myocardium and arterial wall, respectively. This provides a plausible
explanation of equivocal laboratory and imaging results, which,
despite initial reports,72 do not convincingly connect extreme exercise
to adverse cardiovascular events, probably because this benign plaque
composition does not often cause plaque rupture and ACS.73 In accor-
dance with this, in the study by DeFina et al,74 conducted on 21 758
men, higher levels of physical activity were generally associated with
more prevalent coronary artery calcification (CAC) (≥100 Agatston
Units, AU). Nevertheless, in the group with CAC score of at least
100 AU, physical activity of at least 3000 MET-min/week was not
associated with an increased all-cause or cardiovascular disease mor-
tality risk compared to less than 1500 MET-min/week after a decade
of follow-up.
4.4 | Musculoskeletal etiology
Even though the cardiospecificity of the latest generations of cTnT
assays has been validated against skeletal muscle damage,5 recent evi-
dence suggests that skeletal muscle injury might cause elevations at
least of hs-cTnT. Numerous papers have appeared describing frequent
elevations of hs-cTnT (usually without concomitant cTnI elevation) in
myopathies in the absence of any cardiovascular injury, the latter
being excluded after thorough cardiac investigations, including
CMR.75 It should also be noted that troponin elevations may occur in
up to 11% to 30% of cases during rhabdomyolysis, without any signs
of cardiac involvement.76 Skeletal muscle expression of cTn has been
supported by Western blot studies on skeletal muscle biopsies and
has been attributed either to cross reaction with troponin isoforms, or
to re-expression of cardiac isoforms in diseased skeletal muscle,75
although this has been debated by others.77 Lippi et al,36 conducting a
study based on a model of eccentric exercise, a type of muscular
activity sufficient to evoke skeletal, but not myocardial muscle injury,
concluded that skeletal muscular injury might affect the concentration
of hs-TnT for up to 13%. Previous other reports have also provided
evidence correlating cTn to skeletal muscle, rather than to cardiac
parameters (Table 3).78 Finally, even if skeletal muscle etiology cannot
provide a comprehensive answer, contribution, or interference from
skeletal muscle damage should not be overlooked. Numerous studies
have demonstrated cTnI elevations post exercise as well; neverthe-
less, cTnT and cTnI should not be considered interchangeable and this
concept is adopted in the recent MI definition.3
5 | PROGNOSTIC SIGNIFICANCE AND
CLINICAL IMPLICATIONS OF EXERCISE-
INDUCED CTN ELEVATION
It has been consistently demonstrated that resting cTn confers an
increased risk of adverse cardiovascular outcomes even in the
absence of ACS79 and can be a prognosticator in various disease
states,17 or even in healthy individuals.18 Although a large spectrum
of observations has investigated the relationship between exercise
and cTn release, there are only limited data regarding outcomes. Tran-
sient exercise-induced cTn elevation has been generally considered
benign, based on the high frequency it occurs in apparently healthy
asymptomatic individuals, the lack of correlation with functional
(imaging) evidence, and the obvious health benefits provided by
endurance exercise. Siegel et al19 in a previous study employing first-
generation assays, followed nine runners with a postmarathon cTn
increase and showed that all remained asymptomatic for cardiac
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disease 1 year later. In a study by Möhlenkamp et al20 marathon run-
ners with late gadolinium enhancement had higher postrace hsTnI
values compared to those without. However, after a 6-year follow-up
period, coronary event rates were associated with CAC and myocar-
dial fibrosis, but not with increases in hsTnI. Nevertheless, it must be
noted that the relatively small number of participants (74) and events
recorded (6) might have limited the reliability of this report. In contrast
with these evidence, a recent study conducted by Aengevaeren
et al21 in 725 long-distance walkers (61 years on average), found that
troponin I elevations above the 99th percentile after an ultra-
endurance walking event, was associated with higher mortality and
cardiovascular events after 43 months of follow-up, although this
population with relatively increased cardiovascular risk factor burden,
F IGURE 2 Algorithm outlining proposed management of patients with suspected ACS after prolonged exercise algorithm for the initiation of
cardiac troponin (cTn) testing in patients after prolonged exercise, proposed as an adjunct to the standard clinical guidelines for acute coronary
syndrome (ACS). ECG, electrocardiogram60
TABLE 3 In the study by Weippert et al,78 a significant
association was shown between cTnT release and the metabolic state
of the working muscles, that is, exercise “dose,” but not with
echocardiographic parameters. Furthermore, Pearson correlation
analysis presented on figure 3 (unpublished data, personal
communication) reveals strong positive correlation between hs cTnT
and total CK/CK-MB/%CK-MB
cTnT post + 1 cTnT post + 4
Total CK post + 1 0.407 Total CK post + 4 0.509
CK-MB post + 1 −0.172 CK-MB post + 4 0.155
%CK-MB post + 1 −0.315 %CK-MB post + 4 −0.448
Abbreviations: CK-MB, myocardial band isoform of creatine kinase; cTnT,
cardiac troponin T.
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may not be quite representative or comparable with most relevant
studies of athletes. Therefore, recent reports have seriously disputed
the position regarding benign prognosis, indicating that exercise-
induced cTnT elevations may provide incremental prognostic informa-
tion beyond that of baseline values, not only contributing in
unmasking subclinical cardiac pathology,22 but potentially serving as
an early marker of future cardiovascular events as well.21
The potential utility of adding cTn testing in cardiac stress studies,
aiming at improving diagnostic accuracy, have so far proved inconsis-
tent80; however, under the light of latest reports suggesting new sampling
options and prognostic information, this might require reconsideration.
Routine cTn testing is not indicated for the evaluation of individ-
uals who present for medical attention after participation in athletic
events, unless there are specific clinical signs, symptoms, or data
suggesting cardiac involvement.81 In cases of suspicious symptoms, a
careful workup (Figure 2)63 including serial measurements of cTn is
recommended. Clinicians should be aware that remarkable cTn eleva-
tions might occur routinely after prolonged or strenuous endurance
exercise in healthy individuals and in the absence of other signs,
symptoms, or data, should avoid extensive but unnecessary investiga-
tions. In selected cases with low cardiac risk but unexpectedly high
cTnT, additional cTnI or muscle damage markers measurement might
be useful. However, whenever serious cTn elevation is followed by
obvious skeletal muscle injury, but cardiac involvement cannot be eas-
ily excluded (eg, atypical symptoms, high risk factor burden) computed
tomography coronary angiography (CTCA), if available, may represent
a fast, safe and cost effective “rule out” strategy.82
CTCA is favorably incorporated into a triage strategy aiming at
improving the diagnostic efficiency in the emergency department, par-
ticularly in low- to intermediate-risk patients.82 Furthermore, latest
data suggest that CTCA may provide information regarding plaque
morphology and composition, not only offering insights to pathophys-
iological mechanisms, but enhancing cardiac risk prediction as well.83
6 | FUTURE DIRECTIONS
Etiological studies in human and animal models may well be important
avenues for future study. The determination of adequate cardiac and
muscle markers pre and post a strenuous sport event, coupled with
multiple imaging could provide further insights into this topic. The rel-
evance of elevated cTn before and after clinical stress tests in order
to further stratify patients, might be reconsidered. Finally, large pro-
spective studies are needed to explore whether cTn elevations after
physical stress actually confer an incremental risk for future cardiac
events independent of conventional risk markers in a wide range of
active populations.
7 | CONCLUSIONS
Although the etiology remains obscure, numerous reports have demon-
strated that cTn may be elevated in most subjects following various
types of physical activity, ranging from walking to ultra-endurance sports
sessions, in a wide range of populations. It has been suggested that cTn
release is correlated with transient cardiac injury induced by strenuous
exercise; however, the vast majority of studies do not support and asso-
ciation with changes in cardiac function and/or permanent damage/dys-
function. Consequently, exercise-induced cTn elevation has been
considered a benign phenomenon although this position has been chal-
lenged by latest reports. cTn is regarded as highly cardiac specific; never-
theless, it has been recently shown that cTnT increases may be related
to skeletal muscle damage. Awareness that cTn elevations are commonly
seen after exercise may contribute in avoiding unnecessary procedures
in patients admitted to emergency care.
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